Prognostic Value of the Preoperative HALP Score for Survival in Non-Malignant Liver Transplant Recipients
Journal of Clinical Medicine · 30.07.2026 · 15 (15) · 5970
DOI: 10.3390/jcm15155970 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Medicine, online erschienen am 30.07.2026. Verfasst von Muzaffer Atlı und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery, Istanbul Aydın University, 34295 Istanbul, Turkey. Die Arbeit nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background/Objectives: The HALP score is a simple immunonutritional index calculated from routine preoperative hemoglobin, albumin, lymphocyte, and platelet values. We evaluated its association with mortality after liver transplantation for non-malignant indications and its prognostic contribution when considered with the Model for End-stage Liver Disease (MELD) score.
Methods
We retrospectively analyzed 194 adults who underwent liver transplantation for non-malignant disease at a single center between January 2015 and January 2025. The primary outcome was all-cause post-transplant death. The cohort-derived HALP threshold was used for exploratory Kaplan–Meier and Cox analyses, while continuous HALP was examined in sensitivity analyses. Censoring-adjusted cumulative/dynamic ROC analyses evaluated discrimination at 30 days, 90 days, 1 year, and 3 years.
Results
Over a median observed follow-up of 1108 days, 43 recipients (22.2%) died. Non-survivors had lower HALP values than survivors [0.52 (0.39–0.67) vs. 0.77 (0.54–1.04); p < 0.001]. HALP had the highest observed conventional AUC among the evaluated markers for overall mortality (AUC 0.735; 95% CI 0.657–0.814); pairwise AUC differences were not formally tested. The exploratory threshold was 0.6786. Mortality occurred in 36.3% of the low-HALP group and 9.7% of the high-HALP group. After adjustment for MELD and albumin, high versus low HALP remained associated with lower mortality (HR 0.239; 95% CI 0.116–0.493; p < 0.001). HALP also showed consistent time-dependent discrimination across the four evaluated horizons (AUC 0.713–0.738).
Conclusions
Lower preoperative HALP was associated with higher post-transplant mortality in this non-malignant liver transplant cohort. HALP may provide complementary risk information, but the cohort-derived threshold requires independent external validation before clinical use.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of General Surgery, Istanbul Aydın University, 34295 Istanbul, Turkey.
- Department of Gastroenterology and Hepatology, Istanbul Aydın University, 34295 Istanbul, Turkey.
- Department of General Surgery, Ankara Guven Hospital, 06540 Ankara, Turkey.
- Department of General Surgery, Anadolu Medical Center, 41400 Kocaeli, Turkey.
ORCID-Profile: Muzaffer Atlı, Halil Şahin, Lütfi Soylu, Sedat Karademir
Zitieren
APA
Atlı, M., Şahin, H., Soylu, L., & Karademir, S. (2026). Prognostic Value of the Preoperative HALP Score for Survival in Non-Malignant Liver Transplant Recipients. Journal of Clinical Medicine, 15(15), 5970. https://doi.org/10.3390/jcm15155970
Vancouver
Atlı M, Şahin H, Soylu L, Karademir S. Prognostic Value of the Preoperative HALP Score for Survival in Non-Malignant Liver Transplant Recipients. Journal of Clinical Medicine. 2026;15(15):5970. doi:10.3390/jcm15155970
BibTeX
@article{Atl2026,
author = {Atlı, Muzaffer and Şahin, Halil and Soylu, Lütfi and Karademir, Sedat},
title = {Prognostic Value of the Preoperative HALP Score for Survival in Non-Malignant Liver Transplant Recipients},
journal = {Journal of Clinical Medicine},
year = {2026},
volume = {15},
number = {15},
pages = {5970},
doi = {10.3390/jcm15155970}
}
EUVIMED